•
Dec 31, 2023

Select Medical Q4 2023 Earnings Report

Announced results for the fourth quarter and year ended December 31, 2023 and declared a cash dividend.

Key Takeaways

Select Medical Holdings Corporation reported a 4.9% increase in revenue to $1,658.9 million for the fourth quarter ended December 31, 2023. Net income increased 63.9% to $61.8 million, and earnings per common share increased 63.6% to $0.36.

Revenue increased by 4.9% to $1,658.9 million compared to the same quarter last year.

Income from operations increased by 31.5% to $114.3 million compared to the same quarter last year.

Net income increased by 63.9% to $61.8 million compared to the same quarter last year.

Earnings per common share increased by 63.6% to $0.36 compared to the same quarter last year.

Total Revenue
$1.66B
Previous year: $1.58B
+4.9%
EPS
$0.36
Previous year: $0.22
+63.6%
Gross Profit
$158M
Previous year: $173M
-8.6%
Cash and Equivalents
$84M
Previous year: $97.9M
-14.2%
Free Cash Flow
$119M
Total Assets
$7.69B
Previous year: $7.67B
+0.3%

Select Medical

Select Medical

Select Medical Revenue by Segment

Forward Guidance

Select Medical expects revenue to be in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA to be in the range of $830 million to $880 million, and fully diluted earnings per share to be in the range of $1.88 to $2.18 for 2024.

Revenue & Expenses

Visualization of income flow from segment revenue to net income